Cargando...

The pharmacokinetics of xamoterol in liver disease.

The pharmacokinetics of xamoterol, a beta 1-adrenoceptor partial agonist, have been studied in patients with liver disease and a group of age- and sex-matched normal controls. No significant differences were observed after the oral administration of xamoterol 200 mg. The low bioavailability of xamot...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Nicholls, D P, Taggart, A J, McCann, J P, Bastain, W, Shanks, R G
Formato: Artigo
Idioma:Inglês
Publicado: 1989
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1380044/
https://ncbi.nlm.nih.gov/pubmed/2532923
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!